Table 1 Association of DSG3 with clinicopathologic status

From: DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis

Parameter N DSG3 overexpression (%) P-value
   No Yes  
T stage
T1–T2 34 18 (53) 16 (47) 0.009
T3–T4 22 4 (18) 18 (82)  
N stage
N=0 40 19 (47) 21 (53) 0.047
N>0 16 3 (19) 13 (81)  
Overall stage
I–II 24 14 (58) 10 (42) 0.011
III–IV 32 8 (25) 24 (75)  
Differentiation
Well 27 8 (30) 19 (70) 0.153
m-pa 29 14 (48) 15 (52)  
Tumor depth
<10 mm 19 12 (63) 7 (37) 0.009
>10 mm 37 10 (27) 27 (73)  
Extracapsular spread in lymph nodes
No 43 20 (47) 23 (53) 0.044
Yes 13 2 (15) 11 (85)  
Total 56 22 (39) 34 (61)  
  1. am–p: moderate to poor.